SILVER SPRING, Maryland – The U.S. Food & Drug Administration (FDA) has given its tentative approval for emergency authorisation of the coronavirus vaccine developed by Cambridge, Massachusetts- based biotechnology company Moderna Thursday night.
Final FDA sign-off is expected Friday morning. The FDA’s approval came after a panel of experts outside of the agency independently recommended that the agency sign off on immediate use of the vaccine.
The Financial Times reported that Stephen Hahn, the head of the FDA, and Peter Marks, the head of the regulator’s vaccine division, issued a statement on Thursday night that said they had informed Moderna they would work towards the “finalisation and issuance” of an emergency approval.
Read more on losangelesblade.com